GLPG May 2024 32.500 call
| Previous close | 0.3000 |
| Open | 0.3000 |
| Bid | 0.0000 |
| Ask | 5.0000 |
| Strike | 32.50 |
| Expiry date | 2024-05-17 |
| Day's range | 0.3000 - 0.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 16 |
GlobeNewswireGalapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centersCollaboration enables rapid deployment of Galapagos' decentralized CAR-T platform across the U.S., improving patient access to potentially life-saving CAR-T treatmentsImportant milestone for Galapagos' U.S. expansion strategy, supporting upcoming pivotal trials and potential future commercial manufacturing of CAR-T therapiesComplement
Insider MonkeyGalapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call Transcript
Galapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call Transcript May 4, 2024 Galapagos NV isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Sofie Van Gijsel: Welcome all to the audio webcast of Galapagos’ Q1 2024 Results. I’m Sofie Van Gijsel, Investor Relations […]
Simply Wall St.Galapagos First Quarter 2024 Earnings: EPS: €0.36 (vs €0.35 in 1Q 2023)
Galapagos ( AMS:GLPG ) First Quarter 2024 Results Key Financial Results Revenue: €62.4m (down 65% from 1Q 2023). Net...
